Of the 59 PwCF in the CF-GI clinic cohort, there were 29 PwCF who started CFTR modulator during the six-year period of study; of which 10 were prior to the CF-GI clinic first visit, and 19 were after the CF-GI clinic first visit. The gene discussed is CFTR; the disease is cystic fibrosis.